These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20127027)
1. Lewis(y) antigen stimulates the growth of ovarian cancer cells via regulation of the epidermal growth factor receptor pathway. Liu JJ; Lin B; Hao YY; Li FF; Liu DW; Qi Y; Zhu LC; Zhang SL; Iwamori M Oncol Rep; 2010 Mar; 23(3):833-41. PubMed ID: 20127027 [TBL] [Abstract][Full Text] [Related]
2. Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways. Liu D; Liu J; Lin B; Liu S; Hou R; Hao Y; Liu Q; Zhang S; Iwamori M Int J Mol Sci; 2012; 13(1):828-839. PubMed ID: 22312289 [TBL] [Abstract][Full Text] [Related]
3. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway. Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467 [TBL] [Abstract][Full Text] [Related]
4. [Transfection of alpha1, 2-fucosyltransferase gene increases the antigenic expression of Lewis y in ovarian cancer cell line RMG-I]. Lin B; Hao YY; Wang DD; Zhu LC; Zhang SL; Saito M; Iwamori M Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):284-9. PubMed ID: 18686606 [TBL] [Abstract][Full Text] [Related]
5. Alpha 1,3-fucosyltransferase-VII regulates the signaling molecules of the insulin receptor pathway. Wang QY; Zhang Y; Chen HJ; Shen ZH; Chen HL FEBS J; 2007 Jan; 274(2):526-38. PubMed ID: 17229154 [TBL] [Abstract][Full Text] [Related]
6. [alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-I cells]. Hao YY; Lin B; Zhao Y; Zhang YH; Li FF; Diao B; Ou YL; Zhang SL Fen Zi Xi Bao Sheng Wu Xue Bao; 2008 Dec; 41(6):435-42. PubMed ID: 19137814 [TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway]. Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209 [TBL] [Abstract][Full Text] [Related]
9. [Effect of Lewis y antigen on regulating gene expression of partial drug resistance associated proteins in human ovarian cancer cell line RMG-I-H]. Liu Q; Lin B; Wang PL; Yan LM; Hao YY; Li FF; Zhu LC; Zhang SL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug; 31(4):481-7. PubMed ID: 19771739 [TBL] [Abstract][Full Text] [Related]
10. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer. Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907 [TBL] [Abstract][Full Text] [Related]
11. Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. Li H; Schmid-Bindert G; Wang D; Zhao Y; Yang X; Su B; Zhou C Adv Med Sci; 2011; 56(2):275-84. PubMed ID: 22037177 [TBL] [Abstract][Full Text] [Related]
12. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer. Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of fucosyltransferase IV promotes A431 cell proliferation through activating MAPK and PI3K/Akt signaling pathways. Yang XS; Liu S; Liu YJ; Liu JW; Liu TJ; Wang XQ; Yan Q J Cell Physiol; 2010 Nov; 225(2):612-9. PubMed ID: 20506505 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of anti-Lewis y antibody on alpha1,2-fucosyltransferase gene transfected human ovarian cancer cells in vitro]. Li FF; Lin B; Hao YY; Liu JJ; Zhang F; Zhang SL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):267-9. PubMed ID: 18328190 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor. Liu X; Li G Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene. Yan LM; Lin B; Zhu LC; Hao YY; Qi Y; Wang CZ; Gao S; Liu SC; Zhang SL; Iwamori M Biochimie; 2010 Jul; 92(7):852-7. PubMed ID: 20172014 [TBL] [Abstract][Full Text] [Related]
17. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855 [TBL] [Abstract][Full Text] [Related]
18. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines. Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337 [TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells. Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583 [TBL] [Abstract][Full Text] [Related]
20. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression. Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]